Value of next generation sequencing (NGS) testing in advanced cancer patients.

Jesse D Ortendahl Gebra Cuyun Carter Snehal G Thakkar Katalin Bognar David W Hall Yara G Abdou

Published in: Journal of medical economics (2024)

Compared to single-gene testing, results indicate that using next generation sequencing test such as OncoExTra identified more actionable alterations, leading to improved outcomes and reduced costs.

Keyphrases

copy number
circulating tumor
genome wide
dna methylation
type diabetes
gene expression
skeletal muscle
circulating tumor cells
genome wide analysis
cell free